皮质醇作为应激生物标志物:分析视角与挑战
本文综述了皮质醇检测策略的演变,从传统实验室免疫分析到电化学生物传感器、可穿戴设备和微流控系统等先进分析平台。文章指出,准确可靠地检测皮质醇水平升高对于改善应激相关疾病的诊断、治疗和预防策略至关重要,并强调了下一代即时检验系统通过实时生物标志物分析改善早期诊断、治疗监测和个性化医疗的潜力。
要点
- 皮质醇是关键的应激生物标志物,对机体代谢及外周组织和中枢神经系统均有显著影响。
- 检测策略已从传统实验室免疫分析进展到电化学生物传感器、可穿戴设备和微流控系统。
- 纳米材料、传感器设计和数据整合的进步使皮质醇的连续、现场监测成为可能。
核心结论
- 下一代即时检验系统有望通过实时生物标志物分析改善早期诊断、治疗监测和个性化医疗。
研究设计与样本
- 本文为综述,未报告系统检索范围。
主要发现
- 唾液、尿液、毛发、血液和间质液等生物基质含有可用于指示生理障碍的临床显著生物标志物。
- 皮质醇检测策略从传统实验室免疫分析演进至电化学生物传感器、可穿戴设备和微流控系统等先进分析平台。
- 纳米材料、传感器设计和数据整合的最新进展实现了皮质醇水平的连续、现场监测。
关键数值与推荐
- 准确可靠地检测皮质醇水平升高对改善应激相关疾病的诊断、治疗和预防策略至关重要。
临床怎么用
- 下一代即时检验系统可用于应激相关疾病的早期诊断、治疗监测和个性化医疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Point-of-care testing (POCT) has emerged as a transformative approach in modern healthcare for the rapid detection of physiological abnormalities through minimally or non-invasively collected samples. Biological matrices such as saliva, urine, hair, blood, and interstitial fluid contain clinically significant biomarkers that may serve as indicators of physiological disorders. Among these, cortisol is the key stress biomarker and exerts substantial effects on body metabolism, acting on both peripheral tissues and the CNS. This review comprehensively outlines the evolution of cortisol detection strategies, progressing from conventional laboratory-based immunoassays to advanced analytical platforms, including electrochemical biosensors, wearable devices, and microfluidic systems. Accurate and reliable detection of elevated cortisol levels is crucial for improving diagnostic, therapeutic, and preventive strategies for stress-related disorders. By tracing the analytical window, the work describes the detection of cortisol from traditional immunoassays to innovative biosensing platforms. Moreover, recent advances in nanomaterials, sensor design, and data integration have enabled continuous, on-site monitoring of cortisol levels, thereby enhancing their applicability across diverse clinical and non-clinical settings. This integration of physiological insight with technological advancement provides a comprehensive overview of developments in cortisol assessment, connecting fundamental endocrine science with practical diagnostic applications. The review underscores the potential of next-generation POCT systems to improve early diagnosis, therapeutic monitoring, and personalized healthcare through real-time biomarker analysis.
引用
- Suryawanshi R, Sharma S. Cortisol as a stress biomarker: analytical perspectives and challenges. Clin Chim Acta. 2026. PMID: 41999929. doi:10.1016/j.cca.2026.121008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。